trending Market Intelligence /marketintelligence/en/news-insights/trending/kzkQKYitNvP9OHhQH3Jr1Q2 content esgSubNav
In This List

Allergan's topical cream for facial redness gets thumbs up from US FDA

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022

Blog

Insight Weekly: CEO pay jumps; yield curve inversion deepens; wind giants lift turbine prices


Allergan's topical cream for facial redness gets thumbs up from US FDA

The U.S. FDA approved Allergan PLC's Rhofade cream for the treatment of persistent facial redness in adults with rosacea, a common long-term skin disease.

Rhofade will be commercially available in the U.S. starting in May.